Sanbo Hospital Management Group Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Sanbo Hospital Management Group.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Healthcare earnings growth | 23.8% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Sanbo Hospital Management Group (SZSE:301293) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Nov 01Pinning Down Sanbo Hospital Management Group Limited's (SZSE:301293) P/E Is Difficult Right Now
Sep 25The Returns On Capital At Sanbo Hospital Management Group (SZSE:301293) Don't Inspire Confidence
Aug 27What Sanbo Hospital Management Group Limited's (SZSE:301293) P/S Is Not Telling You
Jun 26Investors Could Be Concerned With Sanbo Hospital Management Group's (SZSE:301293) Returns On Capital
May 27Solid Earnings Reflect Sanbo Hospital Management Group's (SZSE:301293) Strength As A Business
Apr 25Sanbo Hospital Management Group Limited's (SZSE:301293) Shares Climb 27% But Its Business Is Yet to Catch Up
Feb 26In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sanbo Hospital Management Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2024 | 1,408 | 110 | -157 | 204 | N/A |
6/30/2024 | 1,377 | 101 | -60 | 233 | N/A |
3/31/2024 | 1,338 | 87 | -20 | 215 | N/A |
12/31/2023 | 1,313 | 78 | 76 | 246 | N/A |
9/30/2023 | 1,204 | 80 | 88 | 207 | N/A |
6/30/2023 | 1,178 | 75 | 89 | 185 | N/A |
3/31/2023 | 1,117 | 74 | 141 | 219 | N/A |
1/1/2023 | 1,070 | 63 | 63 | 153 | N/A |
6/30/2022 | 1,365 | 77 | -73 | 119 | N/A |
3/31/2022 | 1,141 | 74 | -30 | 139 | N/A |
12/31/2021 | 1,137 | 77 | -23 | 122 | N/A |
6/30/2021 | 1,034 | 81 | -336 | 128 | N/A |
3/31/2021 | 1,059 | 71 | -336 | 127 | N/A |
12/31/2020 | 987 | 62 | -336 | 127 | N/A |
12/31/2019 | 1,019 | 51 | 97 | 139 | N/A |
12/31/2018 | 949 | 68 | 100 | 146 | N/A |
12/31/2017 | 809 | 30 | N/A | 83 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 301293's forecast earnings growth is above the savings rate (2.8%).
Earnings vs Market: Insufficient data to determine if 301293's earnings are forecast to grow faster than the CN market
High Growth Earnings: Insufficient data to determine if 301293's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 301293's revenue is forecast to grow faster than the CN market.
High Growth Revenue: Insufficient data to determine if 301293's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 301293's Return on Equity is forecast to be high in 3 years time